La première vague de la COVID-19 aux Soins intensifs

MARCHETTA, Stella; LAMBERMONT, Bernard; MASSION, Paul; ROUSSEAU, Anne-Françoise; LAYIOS, Nathalie; ROBINET, Sébastien; CANIVET, Jean-Luc; KISOKA, Grâce; LEDOUX, Didier; MORIMONT, Philippe; PIRET, Sonia; WIESEN, Patricia; Misset, Benoît

Download

Article (Scientific journals)

La première vague de la COVID-19 aux Soins intensifs

MARCHETTA, Stella; LAMBERMONT, Bernard; MASSION, Paul et al.

2020 • In Revue Médicale de Liège

Peer reviewed

Permalink
https://hdl.handle.net/2268/256821

PubMed
33211418

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Marchetta S et al Rev Med Liege 2020.pdf

Publisher postprint (722.13 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Multiorgan failure; Complications; COVID-19; ARDS; Intensive care; Drug therapy; Invasive ventilation

Abstract :

[en] In December 2019, in Wuhan, a new human infectious pathology was born, COVID-19, consisting above all in pneumoniae, induced by the coronavirus named SARS-CoV-2 because of the respiratory distress it caused (SARS for severe acute respiratory syndrome, and CoV for Coronavirus). A real health and planetary crisis has appeared, much more substantial than that linked to SARS-CoV-1 in 2002-2004 and to MERS-CoV (Middle East Respiratory Syndrome Coronavirus) in 2012. In addition to respiratory damage that can be dramatic, this pathology is complicated by the frequency of cardiovascular, renal and coagulation diseases. Health care systems have had to adapt urgently, in the absence of hindsight from the patho- logy, and without effective therapeutic weapons. Through this review of the literature, we detail our local practices for the overall management of patients hospitalized in Intensive care.

Disciplines :

Anesthesia & intensive care

Author, co-author :

MARCHETTA, Stella

LAMBERMONT, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

MASSION, Paul ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

ROUSSEAU, Anne-Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

LAYIOS, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

ROBINET, Sébastien ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Rythmologie & Pacemaker

CANIVET, Jean-Luc ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

KISOKA, Grâce ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

LEDOUX, Didier ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

MORIMONT, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service des soins intensifs

More authors (3 more)

Language :

English

Title :

La première vague de la COVID-19 aux Soins intensifs

Alternative titles :

[en] The first wave of COVID-19 in Intensive care

Publication date :

2020

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Peer reviewed :

Peer reviewed

Available on ORBi :

since 13 February 2021

Statistics

Number of views

257 (25 by ULiège)

Number of downloads

302 (16 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronarovirus in Wuhan, China. Lancet 2020;395:497-506.
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475-81.
Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020;323:1488-94.
Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARSCoV- 2 admitted to ICUs of the lombardy region, Italy. JAMA 2020;323:1574-81.
Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to Coronavirus Disease 2019. JAMA Netw Open 2020;3:e203976.
Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units - the experience in Sichuan Province, China. Intensive Care Med 2020;46:357-60.
Ethical principles concerning proportionality of critical care during the 2020 COVID-19 pandemic in Belgium: advice by the Belgian Society of Intensive care medicine - update 20-03-2020.
Rosenbaum L. Facing Covid-19 in Italy - ethics, logistics, and therapeutics on the epidemic's front line. N Engl J Med 2020;382:1873-5.
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronarovirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:1-11.
Cheung JC, HO LT, Cheng JV, et al. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med 2020;8:e19.
Namendys-Silva SA. Respiratory support for patients with COVID-19 infection. Lancet Respir Med 2020;8:e18.
Sartini C, Tresoldi M, Scarpellini P, et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit. JAMA 2020;323:2338-40.
Cook TM, El-Boghdadly K, McGuire B, et al. Consensus guidelines for managing the airway in patients with COVID-19. Anaesthesia 2020;75:785-99.
D'Silva DF, McCulloch TJ, LIM JS, et al. Extubation of patients with COVID-19. Br J Anesth 2020;125:e192-5.
Hanidziar D, Bittner EA. Sedation of mechanically ventilated COVID-19 patients: challenges and special considerations. Anesth Analg 2020;131:e40-e41.
Alhazzani W, Hylander Møller M, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87.
Parzibut G, Canivet JL, Guiot J, et al. Le syndrome de détresse respiratoire aiguë. Rev Med Liege 2019;74:514-20.
Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46:1099-102.
Ackermann M, Verleden S, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020;383:120-8.
Hong X, Xiong J, Feng Z, et al. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19? Int J Inf Dis 2020;94:78-80.
Extracorporeal Life Support Organization. ECMO in COVID-19. En ligne: https://www.elso.org/COVID19.aspx. Dernière consultation le 28 août 2020.
Combes A, Cholley B, Lebreton G, et al. Proposition de plan d'action du groupe de réflexion sur l'usage de l'ECMO pour les patients COVID+. En ligne: https://www.arcothova.com/ wp-content/uploads/2020/03/RECO-ECMO-APHP-V2.pdf. Dernière consultation le 28 août 2020.
Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care 2020;58:27-8.
Wu CP, Adhi F, Highland K. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19. Cleve Clin J Med 2020;ccc015.
Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020;116:1666-87.
Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with Covid-10. Kidney Int 2020;98:209-18.
Puelle VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020;383:590-2.
Klok FA, Kruip MJHA, Van der Meer NJM. Incidence of thrombic complications in critically ill ICU patients with covid-19. Thromb Res 2020;191:145-7.
Mucha SR, Dugar S, McCrae K, et al. Coagulopathy in COVID-19. Cleve Clin J Med 2020;87:461-8.
Susen S, Tacquard CA, Godon A, et al. Traitement anticoagulation pour la prévention du risque thrombotique chez un patient hospitalisé avec COVID-19 et surveillance de l'hémostase. Propositions du GIHP et du GFHT. En ligne: https://sfar. org/download/traitement-anticoagulant-pour-la-prevention-durisque- thrombotique-chez-un-patient-hospitalise-avec-covid- 19-et-surveillance-de-lhemostase/. Dernière consultation le 28 août 2020.
Toshiaki I, Levy JH, Connors JM et al. The unique characteristics of COVID-19 coagulopathy. Critical care 2020;24:360.
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review imran. J Clin Neurosci 2020;77:8-12.
Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 2020;43:1027-31.
Guastalegname M, Vallone A. Could chloroquine/hydroxychloroquine be harmful in Coronarovirus Disease 2019 (COVID- 19) treatment? Clin Infect Dis 2020;71:888-9.
Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for Coronavirus Disease 2019 (COVID-19) A Review. JAMA 2020;323:1824-36.
Casey JD, Johnson NJ, Semler MW, et al. ORCHID Protocol Committee and the National Heart, Lung and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) network investigators - rationale and design of ORCHID: a randomized placebo-controlled trial of hydroxychloroquine for adults hospitalized with COVID-19. Ann Am Thorac Soc 2020;17:1144-53..
RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med 2020;NEJMoa2021436.
Beigel JH, Tomashek KM, Mehta AK. Remdesivir for the treatment of Covid-19- preliminary report. N Engl J Med 2020;NEJMoa2007764.
Goldman JD, Lye DCB, HUI DS, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med 2020;NEJMoa2015301.
Villar J, Ferrando C, Martinez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicenter, randomized controlled trial. Lancet Respir Med 2020;8:267-76.
Duana K, Liuc B, Lid C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA 2020;117:9490-6.